LabGenius Therapeutics

London, United Kingdom · Founded 2012 · Privately Held (backing)

Developer of next-generation protein-based therapeutics designed to address unmet needs like inflammatory bowel disease. LabGenius Therapeutics is based in London, United Kingdom and was founded in 2012. Its last reported valuation was $85.9 million in Jul 2025. It has raised $93.4 million.

Last reported valuation

$85.9M

Oct 2026

Priced at

—

Total raised

$93.4M

Last round

—

How much has LabGenius Therapeutics raised?

$93.4Macross 0 recorded rounds

Free account

More of LabGenius Therapeutics with a free account

·The complete investor list: 35 names
·Watch LabGenius Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

LabGenius Therapeutics investors

35 investors are on record for LabGenius Therapeutics, including Innovate UK, Lux Capital, Felicis and Octopus Ventures. By type, the record holds 8 venture capital firms and 2 private investors.

For fundraisers

Raising for a company like LabGenius Therapeutics?

35 investors have backed LabGenius Therapeutics.

See all 35 investors →

Frequently asked about LabGenius Therapeutics

How much has LabGenius Therapeutics raised?: LabGenius Therapeutics has raised $93.4M in total across 0 recorded funding rounds.